BRITTANY LASKO: Open Payments
NPI 1184369555 · SUN CITY, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,630 in 253 payments from 29 companies in 2025. Trend: 2023 $2,249 · 2024 $3,899 · 2025 $3,630
Food & beverage: $3,572Education: $58
| Company | Payments | Amount |
|---|---|---|
| ACADIA Pharmaceuticals Inc | 33 | $490 |
| UCB, Inc. | 29 | $404 |
| ABBVIE INC. | 35 | $356 |
| Teva Pharmaceuticals USA, Inc. | 22 | $324 |
| Amneal Pharmaceuticals LLC | 16 | $259 |
| PFIZER INC. | 16 | $232 |
| Biogen, Inc. | 15 | $202 |
| Neurocrine BioSciences, Inc. | 13 | $179 |
| Eisai Inc. | 7 | $154 |
| Novartis Pharmaceuticals Corporation | 14 | $144 |
Products named: NUPLAZID, CREXONT, Briviact, AUSTEDO XR, NURTEC ODT, INGREZZA, QULIPTA, VUMERITY.
Industry payments across AZ — which companies pay providers there.
